Technical Articles

基于TR-FRET技术的PD1/PD-L1抑制剂作用机制研究
Study on the mechanism of PD1/PD-L1 inhibitors based on TR-FRET technology
发布时间 2026-04-10
PD-1 inhibitors and PD-L1 inhibitors, as immune checkpoint inhibitors targeting the same pathway, enhance T cell recognition and killing of tumor cells by blocking the binding of PD-1 to PD-L1, thereby exerting anti-tumor effects.
View details
  • Cancer
  • TR-FRET Technology
  • PD-1/PD-L1
  • T Cells
IL-21蛋白在肿瘤免疫治疗中的作用机制与联合应用前景
The role and mechanism of IL-21 protein in tumor immunotherapy and its prospects for combination therapy
发布时间 2026-04-02
IL-21 protein belongs to the IL-2 cytokine superfamily and is primarily produced by CD4-positive T cells. It can also be partially secreted by natural killer T cells, follicular helper T cells, and CD8-positive T cells, with some lymphoid hematopoietic cells capable of producing it in small amounts.
View details
  • Cancer
  • IL-21 Protein
  • Tumor Immunotherapy
  • T Cells
IL-5蛋白的生物学功能与临床研究进展
Biological Functions and Clinical Research Progress of IL-5 Protein
发布时间 2026-03-31
IL-5 protein is a pleiotropic cytokine, also known as T-cell replacing factor, eosinophil colony-stimulating factor 1, and eosinophil differentiation factor. This protein is primarily produced by T cells and plays a significant role in immune regulation.
View details
  • Cell Biology
  • IL-5 Protein
  • T Cells
  • Immune Regulation
人Th17极化套装技术原理与应用
Human Th17 Polarization Kit Technology Principle and Application
发布时间 2026-03-17
CD4+辅助性T细胞是适应性免疫应答的核心调节细胞,根据分化方向不同可分为多个功能亚群。其中Th17细胞因其在自身免疫性疾病和宿主防御中的独特作用,成为免疫学研究的热点。
View details
  • Cell Biology
  • Th17 Cells
  • Adaptive Immune Response
  • T Cells
 TNF-α:炎症世界的"核心指挥官"与疾病治疗的革命性靶点 
TNF-α: The "Core Commander" of the Inflammatory World and a Revolutionary Target for Disease Treatment
发布时间 2025-11-23
The full name of TNF-α is tumor necrosis factor-α, primarily produced by activated immune cells such as macrophages and T cells. As a pleiotropic cytokine, it plays a dual role in the human body: both as a defender against infections and as a promoter of tissue damage.
View details
  • Cancer
  • TNF-α
  • Inflammation
  • T cells
  • Pleiotropic cytokine.
搞定T细胞激活:从“摸鱼”到“战斗”的终极开关
Unlocking T-Cell Activation: The Ultimate Switch from Dormancy to Action
发布时间 2025-10-21
As the core component of adaptive immunity, the transition of T cells from a quiescent state to a functionally activated state requires precise regulation by specific signals. This activation process constitutes a fundamental aspect of cellular immunology research and the development of immunotherapies.
View details
  • Signaling Pathway
  • T cells
  • CAR-T
  • the TCR signaling pathway
  • and T-cell activation.
MHC I 四聚体技术:抗原特异性T细胞研究的革命性工具
MHC I tetramer technology: a revolutionary tool for antigen-specific T cell research
发布时间 2025-08-25
In immunological research, how to accurately identify and analyze antigen-specific T cells has always been a core issue. Cytotoxic T cells (CTLs) play a key role in antiviral and anti-tumor immunity by recognizing peptide segments (pMHC) that bind to MHC class I molecules through their T cell receptors (TCR).
View details
  • Immunity/Inflamma
  • MHC I tetramer technology
  • antigens
  • T cells
MHC抗原肽多聚体技术:解锁T细胞免疫研究新维度
MHC antigen peptide oligomerization technology: unlocking new dimensions of T cell immune research
发布时间 2025-08-22
MHC antigen peptide oligomerization technology is a breakthrough tool in modern immunology research. How can it help researchers accurately identify and track antigen-specific T cells? The core of this technology is to utilize the complex formed by the binding of major histocompatibility complex (MHC) molecules with specific antigen peptides, and then enhance the detection sensitivity through polymerization.
View details
  • Cell Biology
  • MHC antigen peptide oligomers
  • T cells
  • immunity
解析MHC I多聚体技术:从分子设计到免疫监测的革新
Deciphering MHC I Multimer Technology: A Revolution from Molecular Design to Immune Monitoring
发布时间 2025-05-12
Cytotoxic T lymphocytes (CTLs), serving as core effector cells in immune responses, execute critical immune surveillance functions through the specific recognition of antigens via their T cell receptors (TCRs). During antigen recognition, the CD8 co-receptor of CTLs collaborates with TCRs to precisely identify antigenic peptides presented by MHC class I molecules.
View details
  • Immunity/Inflamma
  • MHC I oligomerization technology
  • MHC I
  • T cells
H-2Kb MHC四聚体揭示免疫途径对mRNA疫苗诱导肺驻留记忆T细胞分化的调控机制
H-2Kb MHC Tetramer Uncovers Immune Pathways Regulating mRNA Vaccine - Induced Lung - Resident Memory T Cell Differentiation
发布时间 2025-05-12
mRNA vaccination has multiple immunological advantages. It can activate CD8 + T cells and CD4 + T cells and induce antibody production, forming an adaptive immune response network. It doesn't rely on viral - vector delivery systems, avoiding the potential limits of pre - existing vector immunity on booster vaccination. Also, the modular design of its industrial production process enables rapid large - scale preparation.
View details
  • Immunity/Inflamma
  • H-2Kb MHC tetramer
  • mRNA
  • T cells
Total 12
  • 1
  • 2
Go to